Project Grant R15CA305115
Award Date 9/22/25
Completion Date 8/31/28
Dollars Obligated $548K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
- This federal Project Grant award of $123,888.00 from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398) supports research to understand the role of B cells in Merkel cell carcinoma (MCC). The project, awarded to Harvard Medical School, will investigate the adaptive immune response and potential contributions of B cells in both virus-positive and virus-negative subtypes of this rare, aggressive skin cancer. The research aims to provide insights that could...
- This federal Project Grant award of $634,981 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research at the University of Pittsburgh aimed at understanding the role of the Merkel cell polyomavirus (MCV) small T antigen in persistent viral infection. Key research activities include: Investigating how MCV gene expression regulates viral replication, including...
- The federal Project Grant award in the amount of $178,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is funding research at the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts to target the Merkel ST-MYCL-EP400 complex in Merkel cell carcinoma. The research aims to develop innovative approaches to the understanding, detection, and treatment of this rare and aggressive form of skin cancer...
- This federal Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 - Biomedical Research and Research Training program) provides $381,853 to the Regents of the University of Michigan to investigate the nuclear entry mechanisms of DNA viruses. Over the next five years, the research will focus on determining how the oncogenic Merkel cell polyomavirus (MCPyV) and the oncolytic LuIII parvovirus target and cross the nuclear membrane to establish infection, as well...
- This $124,459.00 Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) supports research conducted by President and Fellows of Harvard College (doing business as Harvard Medical School) to investigate the role of the Microphthalmia-associated transcription factor (MITF) and growth factors as initiators of melanoma, the deadliest form of skin cancer. The research leverages a zebrafish model to study melanoma initiation, with a focus on understanding...
- This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Biology Research program (CFDA 93.396), provides $442,236 to the University of Alabama at Birmingham (UAB) from January 1, 2025 through December 31, 2029. The funding supports research to uncover a novel melanoma metastasis pathway driven by the YTHDF1 RNA-binding protein, and to evaluate therapeutic targeting of the IMPDH1 and TRKB/BDNF pathways that mediate this process. The research utilizes...
- The University of New Mexico Health Sciences Center (UNM HSC) was awarded a $544,768 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research federal grant program (CFDA 93.396). The grant supports comprehensive research to understand the fundamental biological mechanisms underlying human papillomavirus (HPV)-related cancers, with a focus on investigating how inhibition of the MEK signaling pathway can lead to tumor regression. Key objectives include...
- This $369,868 federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research to investigate the role of intercellular mitochondrial transfer between nerves and cancer cells, particularly in the context of triple-negative breast cancer metastasis. The project aims to determine how this mitochondrial transfer impacts the metastatic potential of cancer cells and identify key mediators of the process, with the goal of developing potential...
- This federal Project Grant award, valued at $395,509 and provided by the National Cancer Institute (CFDA 93.396 Cancer Biology Research program), supports research aimed at understanding the fundamental biological mechanisms underlying melanoma development and progression. The award, effective from April 4, 2025 through March 31, 2030, is provided to Beth Israel Deaconess Medical Center, Inc. (BIDMC), a prominent non-profit academic medical center in Boston, Massachusetts. The research focuses...
- This federal Project Grant award of $549,836 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to examine the connection between the MYC oncoprotein and the SWI/SNF chromatin remodeling complex in cancers with SMARCA4 mutations. The principal investigator at Middle Tennessee State University will investigate how loss of the BRG1 subunit of SWI/SNF impacts MYC activity and promotes cancer progression. The project aims to provide insights...